Zeiher, Andreas M. 1955-
Zeiher, Andreas-Michael
Zeiher, A.M.
Zeiher, Andreas Michael (1955- )
Andreas Zeiher médecin allemand
VIAF ID: 73262683 ( Personal )
Permalink: http://viaf.org/viaf/73262683
Preferred Forms
- 100 0 _ ‡a Andreas Zeiher ‡c médecin allemand
- 200 _ | ‡a Zeiher ‡b Andreas-Michael
- 100 1 _ ‡a Zeiher, A. M. (sparse)
- 100 1 _ ‡a Zeiher, A.M.
-
- 100 1 _ ‡a Zeiher, Andreas M. ‡d 1955-
-
-
- 100 1 _ ‡a Zeiher, Andreas Michael
-
- 100 1 _ ‡a Zeiher, Andreas-Michael
4xx's: Alternate Name Forms (10)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Adjusted troponin I for improved evaluation of patients with chest pain | |
Alirocumab reduces total nonfatal cardiovascular and fatal events: The ODYSSEY OUTCOMES trial | |
Analyzing the release of copeptin from the heart in acute myocardial infarction using a transcoronary gradient model | |
Aortic stiffness is independently associated with interstitial myocardial fibrosis by native T1 and accelerated in the presence of chronic kidney disease | |
Arteriosclerosis : new insights into pathogenetic mechanisms and prevention | |
ASCVD Risiko Assessment kardiovaskuläre Risikoabschätzung : CardioCard 2020 | |
Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients | |
bioengineered combo dual-therapy CD34 antibody-covered sirolimus-eluting coronary stent in patients with chronic total occlusion evaluated by clinical outcome and optical coherence tomography imaging analysis | |
Bone marrow and plasma FGF‐23 in heart failure patients novel insights into the heart–bone axis | |
Bone marrow-derived progenitors | |
Cathepsin D and H2O2 stimulate degradation of thioredoxin-1: implication for endothelial cell apoptosis | |
Changes in the prevalence, treatment and control of hypertension in Germany? A clinical-epidemiological study of 50.000 primary care patients | |
Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis | |
Clonal hematopoiesis, aging, and cardiovascular diseases | |
consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure update 2016 | |
Contributions toward evidence-based psychocardiology : a systematic review of the literature | |
Daily non‐invasive haemodynamic telemonitoring for efficacy evaluation of MitraClip® implantation in patients with advanced systolic heart failure | |
Differential prognostic accuracy of right ventricular dysfunction, the Seattle heart failure model and the MAGGIC score in patients with severe mitral regurgitation undergoing the MitraClip® procedure | |
Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial | |
Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry | |
Endpoints in stem cell trials in ischemic heart failure | |
Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality | |
GDF-15 predicts cardiovascular events in acute chest pain patients | |
Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation | |
histone acetylase activator pentadecylidenemalonate 1b rescues proliferation and differentiation in the human cardiac mesenchymal cells of type 2 diabetic patients | |
Improved integration of single cell transcriptome data demonstrated on heart failure in mice and men | |
Improved risk stratification in prevention by use of a panel of selected circulating microRNAs | |
Incidence, risk factors and prognostic impact of acute kidney injury after coronary angiography and intervention in kidney transplant recipients: a single-center retrospective analysis | |
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants | |
Kardiovaskuläre Risikoabschätzung in der Hausarztpraxis (DETECT) Wie gut stimmt die Hausarzteinschätzung mit den etablierten Risikoscores überein? | |
Koronare Interventionen in der Therapie der multifokalen Atherosklerose [kumulative Habilitation] | |
Leitliniengerechtes Lipidmanagement LDL-C-Zielwerte bei Hochrisikopatient*innen erreichen | |
Leukocytes carrying Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations invade Human Atherosclerotic Plaques | |
Life beyond 5 Years after TAVI: patients' perceived health status and long-term outcome after transcatheter aortic valve implantation | |
Membranoproliferative Glomerulonephritis Klinik u. Verlauf | |
Myocardial fibrosis and inflammation by CMR predict cardiovascular outcome in people living with HIV | |
Nitric oxide down-regulates MKP-3 mRNA levels: involvement in endothelial cell protection from apoptosis | |
Nitric oxide inhibits caspase-3 by S-nitrosation in vivo | |
Non-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells | |
Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) | |
Oxidative stress and epigenetic regulation in ageing and age-related diseases | |
Phenotypic characterization of miR-92a-/- mice reveals an important function of miR-92a in skeletal development | |
Post-myocardial infarction heart failure dysregulates the bone vascular niche | |
Potential role and prognostic value of erythropoietin levels in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement | |
Prävalenz, medikamentöse Behandlung und Einstellung des Diabetes mellitus in der Hausarztpraxis | |
Prevalence of sleep disordered breathing in patients with primary mitral regurgitation undergoing mitral valve surgery | |
Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol | |
Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information? | |
Risk categorization using New American College of Cardiology / American Heart Association Guidelines for cholesterol management and its relation to alirocumab treatment following acute coronary syndromes | |
SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure - further evidence for improved hemodynamics by continuous pressure monitoring | |
Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation | |
Testosterone is not associated with traits of optimism or pessimism observational evidence from the prospective DETECT study | |
Thirty-day incidence of stroke after transfemoral transcatheter aortic valve implantation: meta-analysis and mixt-treatment comparison of self-expandable versus balloon-expandable valve prostheses | |
TNFα and oxLDL reduce protein S-nitrosylation in endothelial cells | |
Troponin I assay for identification of a significant coronary stenosis in patients with suspected acute myocardial infarction and wide QRS complex | |
Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction | |
Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany | |
Wnt5a increases cardiac gene expressions of cultured human circulating progenitor cells via a PKC delta activation | |
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis |